Clinical Trials Directory

Trials / Completed

CompletedNCT02330172

Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery.

Comparison Sugammadex With Neostigmine in Laryngeal Microsurgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to make a comparison of surgical condition and recovery time between rocuronium 0.45 mg/kg and neostigmine group and rocuronium 0.9 mg/kg and sugammadex group.

Detailed description

This study aims to make a comparison of surgical condition and recovery time between moderate neuromuscular bloackade with reversal using neostigmine group and deep neuromuscular bloackade with reversal using sugammadex group.

Conditions

Interventions

TypeNameDescription
OTHERInjection of neostigmine or sugammadexAt anesthetic induction, rocuronium 0.45 to rocuronium 0.45 - neostigmine group or rocuronium 0.9 mg/kg to rocuronium 0.9 - sugammadex group will be injected for muscle relaxation. During surgical procedure, we will monitor train of four (TOF) using nerve stimulator. After operation, neostigmine 50 mcg/kg or sugammadex 4 mg/kgl be injected.

Timeline

Start date
2014-05-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2015-01-01
Last updated
2017-04-17
Results posted
2017-04-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02330172. Inclusion in this directory is not an endorsement.